BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26986252)

  • 21. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
    Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bortezomib on human neuroblastoma cells in vitro and in a metastatic xenograft model.
    Valentiner U; Haane C; Nehmann N; Schumacher U
    Anticancer Res; 2009 Apr; 29(4):1219-25. PubMed ID: 19414367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.
    Krug S; Kühnemuth B; Griesmann H; Neesse A; Mühlberg L; Boch M; Kortenhaus J; Fendrich V; Wiese D; Sipos B; Friemel J; Gress TM; Michl P
    Endocr Relat Cancer; 2014; 21(6):879-90. PubMed ID: 25248790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.
    Casalà C; Gil-Guiñón E; Ordóñez JL; Miguel-Queralt S; Rodríguez E; Galván P; Lavarino C; Munell F; de Alava E; Mora J; de Torres C
    Carcinogenesis; 2013 Feb; 34(2):268-76. PubMed ID: 23108190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2.
    Li W; Zheng M; Wu S; Gao S; Yang M; Li Z; Min Q; Sun W; Chen L; Xiang G; Li H
    J Exp Clin Cancer Res; 2017 Apr; 36(1):58. PubMed ID: 28427443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
    Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
    Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lentivirus-mediated PLCγ1 gene short-hairpin RNA suppresses tumor growth and metastasis of human gastric adenocarcinoma.
    Zhang B; Wang F; Dai L; Cai H; Zhan Y; Gang S; Hu T; Xia C; Zhang B
    Oncotarget; 2016 Feb; 7(7):8043-54. PubMed ID: 26811493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells.
    Aveic S; Pantile M; Seydel A; Esposito MR; Zanon C; Li G; Tonini GP
    Oncotarget; 2016 Feb; 7(5):5646-63. PubMed ID: 26735175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.
    Bleau AM; Freire J; Pajares MJ; Zudaire I; Anton I; Nistal-Villán E; Redrado M; Zandueta CN; Garmendia I; Ajona D; Blanco D; Pio R; Lecanda F; Calvo A; Montuenga LM
    Int J Cancer; 2014 Dec; 135(11):2516-27. PubMed ID: 24473991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing of TLR4 increases tumor progression and lung metastasis in a murine model of breast cancer.
    Ahmed A; Wang JH; Redmond HP
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S389-96. PubMed ID: 22890596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer.
    Wu Z; Zhang Z; Ge X; Lin Y; Dai C; Chang J; Liu X; Geng R; Wang C; Chen H; Sun M; Guo W; Li J
    Oncotarget; 2015 Dec; 6(38):40519-34. PubMed ID: 26528757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma.
    Liu JF; Tsao YT; Hou CH
    Oncotarget; 2015 Dec; 6(38):40880-95. PubMed ID: 26503469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
    Izraely S; Sagi-Assif O; Klein A; Meshel T; Tsarfaty G; Pasmanik-Chor M; Nahmias C; Couraud PO; Ateh E; Bryant JL; Hoon DS; Witz IP
    Int J Cancer; 2012 Sep; 131(5):1071-82. PubMed ID: 22025079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis.
    Maman S; Edry-Botzer L; Sagi-Assif O; Meshel T; Yuan W; Lu W; Witz IP
    Int J Cancer; 2013 Nov; 133(10):2296-306. PubMed ID: 23649556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PHOX2B is a suppressor of neuroblastoma metastasis.
    Naftali O; Maman S; Meshel T; Sagi-Assif O; Ginat R; Witz IP
    Oncotarget; 2016 Mar; 7(9):10627-37. PubMed ID: 26840262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
    Li X; Wan L; Geng J; Wu CL; Bai X
    J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
    Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.